首页> 外文期刊>Acta crystallographica. Section C, Structural chemistry. >Crystal structure and bonding analysis of the first dinuclear calcium(II)-proton-pump inhibitor (PPI) 'butterfly molecule': a combined microcrystal synchrotron and DFT study
【24h】

Crystal structure and bonding analysis of the first dinuclear calcium(II)-proton-pump inhibitor (PPI) 'butterfly molecule': a combined microcrystal synchrotron and DFT study

机译:第一个二核钙(II)-Proton-pump抑制剂(PPI)'蝴蝶分子'的晶体结构和粘接分析:组合微晶同步rotron和DFT研究

获取原文
获取原文并翻译 | 示例
           

摘要

Proton-pump inhibitors (PPI) are prodrugs used widely to treat acid-related diseases since the late 1980s. After an extensive research effort it has become clear that the fundamental interactions between metal atoms and PPIs are of paramount importance for both drug release and long-term therapeutic safety. Unfortunately, until now, very little information has been available on this topic. In this paper, we report the crystal structure analysis of a novel calcium-PPI compound incorporating bridging and terminal deprotonated (R)-rabeprazole tricyclic ligands (L), namely bis[/x-(i?)-2-({[4-(3-methoxypropoxy)-3-methyl-pyridin-2-yl]methyl}sulfinyl)-6,7-dihydro-3H-benzofuro[5,6-d]imidazol-1-ido]bis-{dimethanol[(R)-2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfin-yl)-6,7-dihydro-3H-benzofuro[5,6-d]imidazol-1-ido]calcium(II)} methanol hexa-solvate, [Ca2(Q0H22N3O4S)4(CH3OH)4]-6CH3OH or [Ca2(L)4(CH3OH)4]-6CH3-OH, which crystallizes from methanol in the polar C2 space group. Using low-temperature microcrystal synchrotron radiation, we demonstrate that this compound is in the form of a beautiful 'butterfly molecule', consisting of a C2-symmetric dinuclear (CH3OH)2LCan(/x2-L)2CanL(HOCH3)2 framework. A large amount of disorder is found within the bridging L ligand and the conformation of the fused tetrahydrofuran ring exhibits great variety. All the sulfinyl groups remain intact and the nonbonded Ca ? -Ca distance is significantly longer than in other calcium dimers, indicating steric hindrance in the bridging ligands. Considerable hydrogen bonding and aromatic C—H- ? -n interactions co-operate to stabilize the whole complex, as well as to facilitate supramolecular assembly. Additional investigations into the bond nature were made using density functional theory (DFT) methods at the B3LYP/6-31G(d) level; geometry optimization, Mulliken atomic charges, MEP (molecular electrostatic potential), HOMO-LUMO (highest occupied molecular orbital-lowest unoccupied molecular orbital), TDOS (total density of states), PDOS (partial density of states), COOP (crystal orbital overlap population) and vibrational spectra were calculated/recorded and assessed carefully.
机译:质子泵抑制剂(PPI)是自20世纪80年代后期以来广泛用于治疗酸相关疾病的前药。经过广泛的研究努力,明显,金属原子和PPI之间的基本相互作用对于药物释放和长期治疗安全性至关重要。不幸的是,直到现在,这主题上有很少的信息。在本文中,我们报告了一种新的钙PPI化合物的晶体结构分析,其掺入桥接和末端去质子化(R)-Rabeprazole三环配体(L),即BIS [/ X-(I =) - 2 - ({[4 - (3-甲氧基丙氧基)-3-甲基 - 吡啶-2-基]甲基}巯基)-6,7-二氢-3H-苯并[5,6-D]咪唑-1-Ido]双 - {二甲醇[( r)-2 - ({[4-甲氧基丙氧基)-3-甲基吡啶-2-基]甲基}巯基-y1)-6,7-二氢-3H-苯并呋喃[5,6-D]咪唑-1 -IdO]甲醇六烷醇溶液,[Ca2(Q0H22N3O4s)4(CH 3 OH)4] -6CH 3 OR或[CA2(L)4(CH 3 OH)4] -6CH3-OH,其从极性的甲醇结晶C2空间组。使用低温微晶同步辐射辐射,我们证明该化合物是美丽的“蝴蝶分子”的形式,由C2对称二核(CH 3 OH)2烷基(HOCH3)2框架组成。在桥接L配体内发现大量的疾病,融合的四氢呋喃环的构象呈现出色。所有亚磺酰基仍然是完整的,并且非粘连的Ca? -CA距离显着长于其他钙二聚体,表明桥接配体中的空间障碍。相当大的氢键和芳香族C-H-? -N相互作用合作以稳定整个复合物,以及促进超分子组装。使用B3LYP / 6-31G(D)水平的密度官能理论(DFT)方法进行额外的调查。几何优化,MELIKEN原子电荷,MEP(分子静电势),HOMO-LUMO(最高占用的分子轨道 - 最低未占用的分子轨道),TDOS(州总密度),PDOS(各状态的部分密度),CEAN(晶体轨道重叠计算/记录/记录和仔细评估群体)和振动光谱。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号